Newswise — WHO: Join Orthopaedic Surgeons, Physicians and the World's Most Promising Cancer Researchers and Educators from the National Cancer Institute, Cornell University, Johns Hopkins University, the University of Pittsburgh, among many others. "¢ Speakers include: 2007 Nobel Prize Laureate, Mario Capecchi, PhDDr. Capecchi will discuss his groundbreaking work with stem cells and implications for soft tissue sarcomas.

FACT: Sarcomas affect both young children and adults. In the past, the only treatment available for osteosarcoma, the second most common bone cancer, was amputation.

FACT: Osteosarcoma, occurs in two to three new people per million each year. It accounts for five percent of all childhood cancers.

FACT: Over the last decade, great strides have been made with stem cells, gene therapy and tissue engineering allow bone cancer patients to possibly avoid amputations. PATIENT STORIES AVAILABLE

WHAT: To explore the very latest bone and tumor cancer treatment options including new and cutting edge information on: "¢ Osteosarcoma"¢ Ewing's Sarcoma"¢ Chrondrosarcoma"¢ Soft Tissue Sarcoma (STS) Download a full Agenda (http://www.aaos.org/research/Committee/research/symposia/mbtmo.asp)

WHY: Symposium allows physicians, educators and researchers more opportunities to explore further cancer treatment options and plans in the research and clinical arenas.

WHEN: September 25 " 27, 2008 Day begins at 7:00 a.m.

WHERE: Hilton Salt Lake City 255 South West Temple Salt Lake City, UT 84101 (801) 328-2000

This symposium is sponsored by: The American Academy of Orthopaedic Surgeons, Orthopaedic Research Society, Orthopaedic Education and Research Foundation, NIH, NCI, NIAMS, NICHD, Musculoskeletal Tumor Society, Musculoskeletal Transplant Foundation, WWWW Foundation, Inc. (QuadW).

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

AAOS/ORS Molecular Biology and Therapeutics in Musculoskeletal Oncology Research Symposium